Header Logo

John Stock

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Raloxifene Hydrochloride
12
2013
19
1.640
 Why?
Osteoporosis, Postmenopausal
12
2013
47
1.430
 Why?
Bone Density Conservation Agents
6
2013
45
0.960
 Why?
Selective Estrogen Receptor Modulators
8
2010
18
0.730
 Why?
Fractures, Bone
7
2010
138
0.720
 Why?
Alendronate
5
2013
14
0.690
 Why?
Spinal Fractures
5
2008
40
0.560
 Why?
Bone Density
8
2013
142
0.410
 Why?
Osteoporosis
3
2008
113
0.310
 Why?
Cardiovascular Diseases
3
2008
859
0.220
 Why?
Breast Neoplasms
5
2013
1211
0.210
 Why?
Double-Blind Method
5
2008
740
0.180
 Why?
Estrogen Replacement Therapy
3
2006
80
0.160
 Why?
Femur Neck
3
2005
12
0.120
 Why?
Diphosphonates
3
2010
33
0.120
 Why?
Middle Aged
10
2013
18106
0.100
 Why?
Absorptiometry, Photon
2
2005
76
0.100
 Why?
Osteoporotic Fractures
1
2013
36
0.100
 Why?
Aged
10
2013
14834
0.100
 Why?
Female
14
2013
33739
0.090
 Why?
Treatment Outcome
5
2010
5758
0.090
 Why?
Risk
3
2008
376
0.080
 Why?
Thiophenes
1
2010
31
0.080
 Why?
Piperidines
1
2010
74
0.080
 Why?
Humans
16
2013
64729
0.080
 Why?
Mortality
1
2010
160
0.070
 Why?
Lumbar Vertebrae
3
2005
174
0.070
 Why?
Postmenopause
4
2010
238
0.060
 Why?
Safety
1
2006
147
0.060
 Why?
Calcitonin
2
2004
17
0.060
 Why?
Venous Thrombosis
1
2006
112
0.060
 Why?
Risk Reduction Behavior
1
2005
121
0.060
 Why?
Clinical Trials as Topic
1
2008
459
0.060
 Why?
Decision Support Techniques
1
2006
193
0.050
 Why?
Randomized Controlled Trials as Topic
3
2004
797
0.050
 Why?
Vitamin D
2
2004
139
0.050
 Why?
Bone and Bones
1
2005
152
0.050
 Why?
Cerebrovascular Disorders
1
2004
83
0.050
 Why?
Follow-Up Studies
2
2010
2483
0.050
 Why?
Hip Fractures
1
2004
77
0.050
 Why?
Calcium
2
2004
583
0.050
 Why?
Estrogen Receptor Modulators
1
2002
7
0.050
 Why?
Medical Records
1
2002
139
0.040
 Why?
Logistic Models
1
2004
1268
0.040
 Why?
Health Care Surveys
1
2002
288
0.040
 Why?
Aged, 80 and over
2
2010
5562
0.040
 Why?
Research Design
1
2002
583
0.040
 Why?
Placebos
2
2010
73
0.030
 Why?
Incidence
2
2008
1409
0.020
 Why?
Women's Health
1
2013
374
0.020
 Why?
Bone Resorption
1
2010
46
0.020
 Why?
Comorbidity
1
2013
1115
0.020
 Why?
Adult
1
2004
17230
0.020
 Why?
Cohort Studies
1
2013
2603
0.020
 Why?
Coronary Disease
1
2008
246
0.020
 Why?
Time Factors
2
2005
3745
0.010
 Why?
Femoral Neck Fractures
1
2005
12
0.010
 Why?
Poisson Distribution
1
2005
52
0.010
 Why?
Bone Remodeling
1
2005
25
0.010
 Why?
Fracture Healing
1
2005
26
0.010
 Why?
Cost-Benefit Analysis
1
2006
315
0.010
 Why?
United States
2
2013
8041
0.010
 Why?
Multicenter Studies as Topic
1
2004
155
0.010
 Why?
Age Distribution
1
2004
258
0.010
 Why?
Hormones
1
2004
62
0.010
 Why?
Estrogens
1
2004
116
0.010
 Why?
Population Surveillance
1
2004
209
0.010
 Why?
Proportional Hazards Models
1
2005
734
0.010
 Why?
Global Health
1
2004
180
0.010
 Why?
Risk Factors
2
2004
5393
0.010
 Why?
Disease Notification
1
2002
6
0.010
 Why?
Patient Selection
1
2004
483
0.010
 Why?
Reference Values
1
2002
328
0.010
 Why?
Mass Screening
1
2006
695
0.010
 Why?
Guidelines as Topic
1
2002
158
0.010
 Why?
Retrospective Studies
1
2013
6803
0.010
 Why?
Prevalence
1
2004
1432
0.010
 Why?
Biomarkers
1
2004
1465
0.010
 Why?
Prospective Studies
1
2004
3299
0.010
 Why?
Surveys and Questionnaires
1
2002
2753
0.010
 Why?
Stock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_